Specialty Pharmacy

Biosimilar trastuzumab antibody (MYL-1401O) comparable in efficacy and safety to targeted cancer drug in women with HER2-positive advanced breast cancer.

Patients receiving intraperitoneal and intravenous chemotherapy had progression-free survival of 59.3 months.

Capecitabine chemotherapy in combination with gemcitabine show median overall survival rate of 28 months.

Anaplastic glioma patients administered temozolomide after radiation, with or without concurrent temozolomide, saw a slower progression of the disease.

Precision medicine found to be associated with increased tumor reduction and progression-free survival.

Access to new cancer medications varies greatly by country.

Overall 3-year survival in patients with advanced melanoma taking pembrolizumab was 40%.

Study finds link between marital bliss and greater risk of diabetes development.

Study finds need for updated pricing system for hepatitis C virus medications.

Alcohol found to affect biologic mechanisms that raise the risk of cancer.

Hsp90 inhibitors target and inactivate a mechanism that cancer cells use to evade standard treatments.

Linagliptin and metformin hydrochloride extended-release tablets approved for adults with type 2 diabetes.

Family caregivers of patients with terminal cancers could benefit from early palliative care.

Growing use of payer rebates among drivers of US drug spending increase.

The critical beginning stages of HIV have been found to be less symptomatic than previously thought.

Genetic variant in the chromosome 5q11 affects development of multiple sclerosis.

HA15 causes melanoma cell death, but does not affect healthy cells.

Ninety-three percent of B-cell acute lymphoblastic leukemia patients treated went into remission in small study.

Top news of the day from across the health care landscape.

Improved cancer detection rates and a reduced recall rates can be enhanced.

Ocaliva approved in combination with ursodeoxycholic acid (UDCA) or as a monotherapy for adults who can’t tolerate UDCA.

Researchers evaluate patient preferences in the treatment of rheumatoid arthritis.

Good bacteria prevented from working effectively in some inflammatory bowel disease patients.

Growing number of patients with life-threatening liver disease being removed from transplant waiting lists.

Long-term exposure to particulate matter increases mortality risk from cancer.

New method may help overcome barriers in patient recruitment to clinical trials.

Fasting-like diet shows promise treating autoimmune diseases in small study.

Top news of the day from across the healthcare landscape.